Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NSCLC Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market by Application
1.3.1 Global NSCLC Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Squamous Cell Lung Carcinoma
1.3.3 Large-cell Lung Carcinoma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global NSCLC Drugs Market Perspective (2018-2033)
2.2 NSCLC Drugs Growth Trends by Region
2.2.1 Global NSCLC Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 NSCLC Drugs Historic Market Size by Region (2018-2023)
2.2.3 NSCLC Drugs Forecasted Market Size by Region (2024-2033)
2.3 NSCLC Drugs Market Dynamics
2.3.1 NSCLC Drugs Industry Trends
2.3.2 NSCLC Drugs Market Drivers
2.3.3 NSCLC Drugs Market Challenges
2.3.4 NSCLC Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NSCLC Drugs Players by Revenue
3.1.1 Global Top NSCLC Drugs Players by Revenue (2018-2023)
3.1.2 Global NSCLC Drugs Revenue Market Share by Players (2018-2023)
3.2 Global NSCLC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NSCLC Drugs Revenue
3.4 Global NSCLC Drugs Market Concentration Ratio
3.4.1 Global NSCLC Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NSCLC Drugs Revenue in 2022
3.5 NSCLC Drugs Key Players Head office and Area Served
3.6 Key Players NSCLC Drugs Product Solution and Service
3.7 Date of Enter into NSCLC Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NSCLC Drugs Breakdown Data by Type
4.1 Global NSCLC Drugs Historic Market Size by Type (2018-2023)
4.2 Global NSCLC Drugs Forecasted Market Size by Type (2024-2033)
5 NSCLC Drugs Breakdown Data by Application
5.1 Global NSCLC Drugs Historic Market Size by Application (2018-2023)
5.2 Global NSCLC Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America NSCLC Drugs Market Size (2018-2033)
6.2 North America NSCLC Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America NSCLC Drugs Market Size by Country (2018-2023)
6.4 North America NSCLC Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe NSCLC Drugs Market Size (2018-2033)
7.2 Europe NSCLC Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe NSCLC Drugs Market Size by Country (2018-2023)
7.4 Europe NSCLC Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NSCLC Drugs Market Size (2018-2033)
8.2 Asia-Pacific NSCLC Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific NSCLC Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific NSCLC Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America NSCLC Drugs Market Size (2018-2033)
9.2 Latin America NSCLC Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America NSCLC Drugs Market Size by Country (2018-2023)
9.4 Latin America NSCLC Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NSCLC Drugs Market Size (2018-2033)
10.2 Middle East & Africa NSCLC Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa NSCLC Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa NSCLC Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck NSCLC Drugs Introduction
11.1.4 Merck Revenue in NSCLC Drugs Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb NSCLC Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2018-2023)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Regeneron Pharmaceuticals
11.3.1 Regeneron Pharmaceuticals Company Detail
11.3.2 Regeneron Pharmaceuticals Business Overview
11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Introduction
11.3.4 Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2018-2023)
11.3.5 Regeneron Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis NSCLC Drugs Introduction
11.4.4 Novartis Revenue in NSCLC Drugs Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Jiangsu Hengrui Medicine
11.5.1 Jiangsu Hengrui Medicine Company Detail
11.5.2 Jiangsu Hengrui Medicine Business Overview
11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Introduction
11.5.4 Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2018-2023)
11.5.5 Jiangsu Hengrui Medicine Recent Development
11.6 Innovent Biologics
11.6.1 Innovent Biologics Company Detail
11.6.2 Innovent Biologics Business Overview
11.6.3 Innovent Biologics NSCLC Drugs Introduction
11.6.4 Innovent Biologics Revenue in NSCLC Drugs Business (2018-2023)
11.6.5 Innovent Biologics Recent Development
11.7 Shanghai Junshi Biosciences
11.7.1 Shanghai Junshi Biosciences Company Detail
11.7.2 Shanghai Junshi Biosciences Business Overview
11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Introduction
11.7.4 Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2018-2023)
11.7.5 Shanghai Junshi Biosciences Recent Development
11.8 BeiGene
11.8.1 BeiGene Company Detail
11.8.2 BeiGene Business Overview
11.8.3 BeiGene NSCLC Drugs Introduction
11.8.4 BeiGene Revenue in NSCLC Drugs Business (2018-2023)
11.8.5 BeiGene Recent Development
11.9 Roche
11.9.1 Roche Company Detail
11.9.2 Roche Business Overview
11.9.3 Roche NSCLC Drugs Introduction
11.9.4 Roche Revenue in NSCLC Drugs Business (2018-2023)
11.9.5 Roche Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca NSCLC Drugs Introduction
11.10.4 AstraZeneca Revenue in NSCLC Drugs Business (2018-2023)
11.10.5 AstraZeneca Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer NSCLC Drugs Introduction
11.11.4 Pfizer Revenue in NSCLC Drugs Business (2018-2023)
11.11.5 Pfizer Recent Development
11.12 Boehringer-Ingelheim
11.12.1 Boehringer-Ingelheim Company Detail
11.12.2 Boehringer-Ingelheim Business Overview
11.12.3 Boehringer-Ingelheim NSCLC Drugs Introduction
11.12.4 Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2018-2023)
11.12.5 Boehringer-Ingelheim Recent Development
11.13 Teva
11.13.1 Teva Company Detail
11.13.2 Teva Business Overview
11.13.3 Teva NSCLC Drugs Introduction
11.13.4 Teva Revenue in NSCLC Drugs Business (2018-2023)
11.13.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global NSCLC Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral Type
Table 3. Key Players of Injection Type
Table 4. Global NSCLC Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global NSCLC Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global NSCLC Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global NSCLC Drugs Market Share by Region (2018-2023)
Table 8. Global NSCLC Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global NSCLC Drugs Market Share by Region (2024-2033)
Table 10. NSCLC Drugs Market Trends
Table 11. NSCLC Drugs Market Drivers
Table 12. NSCLC Drugs Market Challenges
Table 13. NSCLC Drugs Market Restraints
Table 14. Global NSCLC Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global NSCLC Drugs Market Share by Players (2018-2023)
Table 16. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSCLC Drugs as of 2022)
Table 17. Ranking of Global Top NSCLC Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by NSCLC Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NSCLC Drugs Product Solution and Service
Table 21. Date of Enter into NSCLC Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NSCLC Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global NSCLC Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global NSCLC Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global NSCLC Drugs Revenue Market Share by Type (2024-2033)
Table 27. Global NSCLC Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global NSCLC Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global NSCLC Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global NSCLC Drugs Revenue Market Share by Application (2024-2033)
Table 31. North America NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America NSCLC Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America NSCLC Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe NSCLC Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe NSCLC Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific NSCLC Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific NSCLC Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific NSCLC Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America NSCLC Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America NSCLC Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa NSCLC Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa NSCLC Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa NSCLC Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck NSCLC Drugs Product
Table 49. Merck Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Bristol-Myers Squibb Company Detail
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb NSCLC Drugs Product
Table 54. Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. Regeneron Pharmaceuticals Company Detail
Table 57. Regeneron Pharmaceuticals Business Overview
Table 58. Regeneron Pharmaceuticals NSCLC Drugs Product
Table 59. Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 60. Regeneron Pharmaceuticals Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis NSCLC Drugs Product
Table 64. Novartis Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Jiangsu Hengrui Medicine Company Detail
Table 67. Jiangsu Hengrui Medicine Business Overview
Table 68. Jiangsu Hengrui Medicine NSCLC Drugs Product
Table 69. Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 70. Jiangsu Hengrui Medicine Recent Development
Table 71. Innovent Biologics Company Detail
Table 72. Innovent Biologics Business Overview
Table 73. Innovent Biologics NSCLC Drugs Product
Table 74. Innovent Biologics Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 75. Innovent Biologics Recent Development
Table 76. Shanghai Junshi Biosciences Company Detail
Table 77. Shanghai Junshi Biosciences Business Overview
Table 78. Shanghai Junshi Biosciences NSCLC Drugs Product
Table 79. Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 80. Shanghai Junshi Biosciences Recent Development
Table 81. BeiGene Company Detail
Table 82. BeiGene Business Overview
Table 83. BeiGene NSCLC Drugs Product
Table 84. BeiGene Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 85. BeiGene Recent Development
Table 86. Roche Company Detail
Table 87. Roche Business Overview
Table 88. Roche NSCLC Drugs Product
Table 89. Roche Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 90. Roche Recent Development
Table 91. AstraZeneca Company Detail
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca NSCLC Drugs Product
Table 94. AstraZeneca Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. Pfizer Company Detail
Table 97. Pfizer Business Overview
Table 98. Pfizer NSCLC Drugs Product
Table 99. Pfizer Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. Boehringer-Ingelheim Company Detail
Table 102. Boehringer-Ingelheim Business Overview
Table 103. Boehringer-Ingelheim NSCLC Drugs Product
Table 104. Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 105. Boehringer-Ingelheim Recent Development
Table 106. Teva Company Detail
Table 107. Teva Business Overview
Table 108. Teva NSCLC Drugs Product
Table 109. Teva Revenue in NSCLC Drugs Business (2018-2023) & (US$ Million)
Table 110. Teva Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSCLC Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global NSCLC Drugs Market Share by Type: 2022 VS 2033
Figure 3. Oral Type Features
Figure 4. Injection Type Features
Figure 5. Global NSCLC Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global NSCLC Drugs Market Share by Application: 2022 VS 2033
Figure 7. Squamous Cell Lung Carcinoma Case Studies
Figure 8. Large-cell Lung Carcinoma Case Studies
Figure 9. NSCLC Drugs Report Years Considered
Figure 10. Global NSCLC Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global NSCLC Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global NSCLC Drugs Market Share by Region: 2022 VS 2033
Figure 13. Global NSCLC Drugs Market Share by Players in 2022
Figure 14. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSCLC Drugs as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by NSCLC Drugs Revenue in 2022
Figure 16. North America NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America NSCLC Drugs Market Share by Country (2018-2033)
Figure 18. United States NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe NSCLC Drugs Market Share by Country (2018-2033)
Figure 22. Germany NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific NSCLC Drugs Market Share by Region (2018-2033)
Figure 30. China NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America NSCLC Drugs Market Share by Country (2018-2033)
Figure 38. Mexico NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa NSCLC Drugs Market Share by Country (2018-2033)
Figure 42. Turkey NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia NSCLC Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Merck Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 45. Bristol-Myers Squibb Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 46. Regeneron Pharmaceuticals Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 48. Jiangsu Hengrui Medicine Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 49. Innovent Biologics Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 50. Shanghai Junshi Biosciences Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 51. BeiGene Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 52. Roche Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 53. AstraZeneca Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 54. Pfizer Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 55. Boehringer-Ingelheim Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 56. Teva Revenue Growth Rate in NSCLC Drugs Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed